Exploring microRNAs in Bile Duct Stents as Diagnostic Biomarkers for Biliary Pathologies

In summary, bile duct stents can be considered as potential sources of intraductal biomarkers, specifically miRNAs. Further profiling and validation analyses are necessary to identify the most appropriate miRNA targets for differentiating bile duct diseases.

Authors

Institutions

Publication Details

Journal
Cancers
Published
2025-03-31
DOI
https://doi.org/10.3390/cancers17071171
Primary Topic
Pediatric Hepatobiliary Diseases and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Exploring microRNAs in Bile Duct Stents as Diagnostic Biomarkers for Biliary Pathologies

Konrad Lehr, Alexander Link, Wilfried Obst, Manuele Furnari et al.
Cancers
Pediatric Hepatobiliary Diseases and Treatments
article

Exploring microRNAs in Bile Duct Stents as Diagnostic Biomarkers for Biliary Pathologies

Konrad Lehr, Alexander Link, Wilfried Obst, Manuele Furnari, Cosima Thon, Verena Keitel, Jochen Weigt, N. Hipler
article en

Abstract

In summary, bile duct stents can be considered as potential sources of intraductal biomarkers, specifically miRNAs. Further profiling and validation analyses are necessary to identify the most appropriate miRNA targets for differentiating bile duct diseases.

CancersVol. 17(7)
Ospedale Policlinico San Martino (IT), University of Genoa (IT), Otto-von-Guericke-Universität Magdeburg (DE)
Openalex Percentile: Top 89%
Pediatric Hepatobiliary Diseases and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.